tiprankstipranks
Trending News
More News >
Magle Chemoswed Holding AB (DE:52X)
FRANKFURT:52X

Magle Chemoswed Holding AB (52X) Price & Analysis

Compare
0 Followers

52X Stock Chart & Stats


Financials

52X FAQ

What was Magle Chemoswed Holding AB’s price range in the past 12 months?
Magle Chemoswed Holding AB lowest stock price was €2.26 and its highest was €3.70 in the past 12 months.
    What is Magle Chemoswed Holding AB’s market cap?
    Magle Chemoswed Holding AB’s market cap is €51.07M.
      When is Magle Chemoswed Holding AB’s upcoming earnings report date?
      Magle Chemoswed Holding AB’s upcoming earnings report date is Aug 01, 2025 which is in 21 days.
        How were Magle Chemoswed Holding AB’s earnings last quarter?
        Magle Chemoswed Holding AB released its earnings results on May 22, 2025. The company reported -€0.009 earnings per share for the quarter, missing the consensus estimate of €0.045 by -€0.054.
          Is Magle Chemoswed Holding AB overvalued?
          According to Wall Street analysts Magle Chemoswed Holding AB’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Magle Chemoswed Holding AB pay dividends?
            Magle Chemoswed Holding AB pays a Notavailable dividend of €0.032 which represents an annual dividend yield of N/A. See more information on Magle Chemoswed Holding AB dividends here
              What is Magle Chemoswed Holding AB’s EPS estimate?
              Magle Chemoswed Holding AB’s EPS estimate is <0.01.
                How many shares outstanding does Magle Chemoswed Holding AB have?
                Magle Chemoswed Holding AB has 20,516,045 shares outstanding.
                  What happened to Magle Chemoswed Holding AB’s price movement after its last earnings report?
                  Magle Chemoswed Holding AB reported an EPS of -€0.009 in its last earnings report, missing expectations of €0.045. Following the earnings report the stock price went same 0%.
                    Which hedge fund is a major shareholder of Magle Chemoswed Holding AB?
                    Currently, no hedge funds are holding shares in DE:52X

                    Company Description

                    Magle Chemoswed Holding AB

                    Magle Chemoswed Holding AB (publ) engages in the research, development, and manufacturing in the areas of pharmaceutical chemistry and pharmaceutical technology in Sweden. The company focuses on the process development and manufacture of active pharmaceutical ingredients (API); and research, development, and production of products in the areas of wound care and diagnostics with a focus on products based on degradable starch microspheres. Its APIs include Warfarin sodium products that are used as anticoagulants for multiple indications; Melperone hydrochloride, which is an antipsychotic agent; Isradipine, a calcium channel blocker used to treat hypertension; Amantadine sulfate that is used in the treatment of central nervous system disorders; and Benserazide hydrochloride, which is used in combination with L-Dopa in the treatment of Parkinson's disease. The company also offers medical devices for applications in the areas of advanced wound care, surgical and diagnostics, and drug delivery comprising EmboCept S, a microsphere based medical device used in vascular occlusion of liver and lung tumors; SmartGel, a non-allergenic hydrogel based on the company's unique microsphere technology; SmartPAN, a medical device for the detection of pancreatic fluid leakage during open or minimally invasive surgical procedures; and EmboCept M, a device for use in the treatment of benign prostatic hyperplasia. It serves companies in the pharmaceutical and medical device industry on a contract basis. The company was founded in 1944 and is headquartered in Malmö, Sweden. Magle Chemoswed Holding AB (publ) is a subsidiary of Magle AB.
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Infant Bacterial Therapeutics AB
                    SynAct Pharma AB
                    Saniona AB
                    IRLAB Therapeutics AB Class A
                    Cantargia AB
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis